Magrabi Health has partnered with Digital Diagnostics and Tamer Healthcare to launch LumineticsCore™, an AI system for detecting diabetic retinopathy, at its Eye Hospital in Riyadh. LumineticsCore, developed by Digital Diagnostics, is the first FDA and SFDA-approved autonomous AI system for diagnosing this leading cause of vision loss. This collaboration aligns with Magrabi Health's rebranding efforts and Saudi Vision 2030's focus on healthcare digitalization.

With diabetes affecting over 7 million people in Saudi Arabia, this technology aims to improve patient outcomes by enabling early detection and treatment. Tamer Healthcare, with its expertise in healthcare products and services, supports this initiative by enhancing healthcare accessibility and innovation.

Magrabi Health, founded in 1955, continues to lead in specialized healthcare, and this partnership reaffirms its commitment to integrating advanced technology to provide the highest standards of care.